AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
BIFONAZOLE
5 registrations across 4 African markets— 3 active
Markets with BIFONAZOLE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MYCODEAL SOLUTION Solution | 🇷🇼Rwanda | BIODEAL LABORATORIES LIMITED | active | Sept 2029 |
| CANESPOR CREAM; TOPICAL | 🇿🇼Zimbabwe | BAYER (PTY) LTD | active | Dec 2027 |
| CANESPOR CREAM | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | suspended | May 2023 |
| CANESPOR SOLUTION | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | suspended | May 2023 |
| MYCOSPOR CREME | 🇲🇦Morocco | — | active | — |
BIFONAZOLE in Africa — Regulatory Overview
BIFONAZOLE is registered across 4 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Morocco, Rwanda, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 3 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.